In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
The launch of weight-loss pills is the hottest battle in pharma. So far, Eli Lilly LLY 1.15%increase; up…
EMA Recommends Approval of Novo Nordisk Wegovy Weight-Loss Pill
The European Medicines Agency recommended the approval of Novo Nordisk’s Wegovy weight-loss pill Friday, paving the way for…
Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide
Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide’s favourable hepatic profile in patients with Metabolic Dysfunction-associated…